Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Adaptimmune Therapeutics PLC (ADAP)
Adaptimmune Therapeutics PLC (ADAP) Financials

ADAP Adaptimmune Therapeutics PLC

0.59

-0.0014 (-0.24%)

18 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-28.528	-27.095	-32.115	-59.06	-41.124	-34.342	-41.444	-37.241
Return on Equity (%)	-37.337	-37.549	-39.621	-72.817	-55.97	-57.783	-114.965	-187.61
Return on Invested Capital (%)	-39.839	-41.9	-37.554	-75.864	-58.305	-58.316	-118.165	-204.198
Operating Margin (%)	-519.622	-211.252	-180.612	-12203.476	-3282.719	-2558.123	-600.262	-186.684
Net Profit Margin (%)	-484.568	-188.481	-153.861	-12225.045	-3286.812	-2570.987	-609.459	-188.9
Book Value Per Share	0.388	0.359	0.391	0.192	0.366	0.219	0.082	0.029
Earnings Per Share	-0.162	-0.127	-0.146	-0.217	-0.14	-0.169	-0.168	-0.084
Cash Per Share	0.374	0.15	0.109	0.08	0.061	0.16	0.109	0.106
Working Capital Per Share	0.373	0.277	0.329	0.137	0.387	0.376	0.193	0.099
Operating Profit Per Share	0.038	0.07	0.097	0.031	0.028	0.049	0.06	0.075
EBIT Per Share	-0.174	-0.143	-0.172	-0.217	-0.14	-0.168	-0.165	-0.083
EBITDA Per Share	-0.174	-0.143	-0.172	-0.217	-0.14	-0.168	-0.165	-0.083
Free Cash Flow Per Share	-0.133	-0.09	-0.151	-0.225	-0.145	-0.166	-0.144	-0.087

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	424.78M	562.12M	627.45M	631M	928.76M	937.55M	987.11M	1.36B

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	987.11M	993.7M	1.35B	1.36B	1.36B	1.53B	1.53B	1.53B
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	3.489	N/A	N/A	N/A	-844.963	N/A	N/A
Net Profit Margin (%)	N/A	2.176	N/A	N/A	N/A	-854.227	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	151.33M
Price to Earnings Ratio	-1.35
Price to Sales Ratio	2.55
Price to Cash Ratio	1.07
Price to Book Ratio	3.89
Dividend Yield	-

Share Statistics

Shares Outstanding	255.88M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Adaptimmune Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions